Egis Pharmaceuticals Ltd. has unveiled one of the most significant developments in its 112-year history in Budapest. The company will manufacture the active ingredient for a globally leading product at its new HUF 30 billion plant, which was financed from its own resources, the company told MTI on Thursday. According to the announcement, what makes […]
The post Egis Inaugurates HUF 30 Bn Active Ingredient Plant appeared first on Diplomacy & Trade.
